Jim Cramer offers his grading system for this earnings season and advised investors which stock is at the top of his class. » Read More
PENNSAUKEN, N.J. _ J&J Snack Foods Corp. on Monday reported fiscal third-quarter profit of $26.8 million. J&J Snack Foods shares have risen almost 4 percent since the beginning of the year. Keywords: J&J Snack Foods, Earnings Report.
Plenty of trading tax proposals have been floated around by politicians, but how effective would they really be?
GM's blowout report today just gave a big boost to quarterly estimates.
The U.S. consumer has grown remarkably resilient, according to a new report. Two key sectors are driving the spending.
Netflix Inc., down $12.97 to $85.84. VMWare Inc., up $5.66 to $68.23. Johnson& Johnson, up $2.11 to $125.25.
Wall Street pulled back Tuesday after stocks hit record levels this week and investors digested second-quarter earnings.
Solid quarterly numbers are giving investors plenty of hope for earnings right out of the gate so far in Q2.
Netflix and other companies reported disappointing results, and the International Monetary Fund predicted a slowdown in the United Kingdom's economy following its vote to leave the European Union. THE RUN THAT WAS: The S&P 500 had surged just over 8 percent since June 27, when stocks hit a bottom following the United Kingdom's vote. GLOBAL MARKETS: Japan's...
Stocks are ending mostly lower on Wall Street as a three-week rally loses momentum. Health care giant Johnson& Johnson rose 1.7 percent after reporting earnings that beat analysts' forecasts. Stocks are slipping in midday trading on Wall Street as a three-week rally loses momentum.
Jim Cramer explains what to watch ahead of the open, including the outlook for Johnson & Johnson.
U.S. stock futures pointed to a higher open Tuesday as investors digested second-quarter earnings.
Johnson & Johnson reported a 3.9 percent increase in second-quarter sales, helped by strength in its pharmaceuticals business.
Netflix, Goldman Sachs and Johnson & Johnson are making headlines this Tuesday morning.
Some of the names on the move ahead of the open.
Johnson & Johnson CFO and CFO Council member Dominic Caruso sits down on Squawk Box to discuss Johnson & Johnson's earnings, the company's iconic brands and the outook on its medical and pharma business.
Surging second-quarter sales of Johnson& Johnson's prescription drugs, its healthiest business, were more than offset by a one-time gain a year ago, driving profit down 11.5 percent. But the health care giant easily beat Wall Street's expectations and raised its full-year financial forecasts. The world's biggest maker of health care products reported net...
Japan's index jumped on a weaker yen and a Pokemon-powered rally in Nintendo shares. KEEPING SCORE: France's CAC 40 was down 0.8 percent at 4,324 and Germany's DAX shed 1 percent to 9,963. Britain's FTSE 100 lost 0.2 percent to 6,684. U.S. stocks were poised for a subdued open, with Dow futures unchanged and the broader S&P 500 futures down 0.2 percent.
The "Halftime Report" experts discuss whether to buy these stocks ahead of earnings
Today kicks off a huge week for earnings. The "FMHR" traders discuss their views on some key reports including IBM, Netflix and more.
Jim Cramer shares his game plan of stocks to watch next week.